Teneligliptin is a Medicine belongs to Antidiabetic group whose information about Brand can be referenced from   Book : Martindale    Page : 504   Edition : 38      Page :   Edition :   

  ►   Brandname : Tenelia, Dynaglipt, Dynaglipt M
  ►  Strength : Tablet with

Reference of this Medicine for its Strength can be taken from   Book : Martindale    Page : 504   Edition : 38  
A Route of administration in pharmacology and toxicology is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration.

  ►  Route of administration : Oral
Reference :-   Book : Martindale    Page : 500   Edition : 38  

Dosing of Medicine differ in Adult & Pediatrics ↓

Adult Dose

S.No Ailment   Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency   Additional Info
1 N.F.R.B

Ref :-  Book :    Page :    Edition :   



Pediatric Dose

S.No Ailment   Age Min   Age Max   Weight ( Kg ) Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency  Additional Info  
1

Ref :- Book :    Page :    Edition :   
►  Side Effect : Headache, Dizziness, Gastrointestinal disturbance, Peripheral oedema, Upper respiratory-tract infections, Nasopharyngitis, Rashes, Hypersenstivity, Anaphylaxis, Angioedema, Urticaria, Cutaneous vasculitis, Stevens-Johnson syndrome, Elevated liver enzyme values, Pancreatitis, Impaired renal function, Acute renal failure
Ref :-   Book : Martindale    Page : 500,504   Edition : 37.   Martindale    Page : 500,504   Edition : 38.  

►  Drug Interaction : Drug interaction of Teneligliptin is with NA

  ►    Mechanism of Drug Drug Interaction :  The efficacy of sitagliptin may be affected by other drugs that have an independent effect on blood glucose. Drugs that can increase or decrease blood glucose concentrations.
Ref :-   Book : Martindale    Page : 500,504   Edition : 38.  


►  Contraindication : Type 1 diabetes mellitus, Diabetic ketoacidosis, Moderate and severe renal impairment
Ref :-   Book : Martindale    Page : 500   Edition : 38.   Martindale    Page : 500,504   Edition : 38.  
  ►  Mechanism of Action :   Inhibits dipeptidylpeptidase-4, , an enzyme responsible, among other roles, for the degradation of the incretin hormone glucagon-like peptide-1 (GLP-1); and glucose-dependent insulinotropic polypeptide (GIP).
Ref :-   Book : Martindale    Page : 500,504   Edition : 38.  

Pathway of DIETARY Product


​   ► Act.Comp / Nutrient / Food / Herb as follows :- NA


DIETARY Substance Interactions


​   ► This Medicine interact with :- NA



ContraIndication DIETARY Substance


​   ► This Medicine contraindicate with :- NA

►   Route of Elimination :   NA

►    Plasma Half-life :   Min value :-   NA    Max value :-   NA

►    Peak Plasma Concentration :   Min value :-   NA    Max value :-   NA